Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People In Brief

This article was originally published in The Gray Sheet

Executive Summary

Cardinal Health names new CEO: After 32 years with Proctor & Gamble, R. Kerry Clark joins Cardinal as CEO on April 17. Clark succeeds Cardinal Health founder and CEO Robert Walter, who will continue on as chairman of the board. Cardinal also announced that George Fotiades will leave the company after serving two years as COO...

You may also be interested in...



B&L Pulls Contact Lens Solution To Investigate Adverse Events

A possible association between one of Bausch & Lomb's newest contact lens solutions - ReNu with MoistureLoc - and a rash of serious eye infections could have implications for the firm's broader eye care business, analysts say. However, the company is mounting an aggressive marketing campaign to counteract the negative momentum

Reprocessors Forge Ahead Despite Heavy Regulatory, Political Attention

Recent changes to federal device branding requirements do not pose a significant barrier to third-party reprocessing, according to Alliance Medical President and Chief Operating Officer Rick Ferreira

New EU Filings

Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT023482

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel